The Potential Therapeutic Advantage of Abrus precatorius Linn. an Alternative to Glycyrrhiza glabra: A Review
Ashaolu Victoria Oladimeji, M. F. Valan
Journal of Pharmaceutical Research International · pp. 79–94 · Published 11 Jan 2021
10.9734/jpri/2020/v32i4031035Abstract
Far back since the existence of the human race, plant species have been used as herb or medicine to either treat, suppress or cure the human numerous sicknesses. This poses the truth that green medicine is safe, cost-efficient, and effective with little or no side effects. Up-till date, the medicinal plant has gained world attraction which has led to global development and discovery of new drug formulations. The beneficial features of plant medicine are enormous and should not be under-estimated. However, in this study, Abrus precatorius Linn., an alternative to Glycyrrhiza glabra has been extensively reviewed to expose this herb secret to the scientific research world for the development of possible novel drug formulations in response to the present global diseases around the globe.
Cited by 15
Sakshi Dadaso Pawar, Sakharam Sampat Bhutekar, Rushikesh Raju Gaikwad · Journal of Drug Delivery and Therapeutics · 2025
Shubhangi Sutar, Ankita Patil, Rachana Bhimanwar · Natural Product Research · 2026
Huiqin Qian, Lu Wang, Yanling Li · Journal of Ethnopharmacology · 2022
Babeeta C. Kaula, Reema Mishra, Geeta · Vegetos · 2022
Showing 4 of 15 known citations — external sources report more than can currently be individually listed.
Related research
- Analyzing Different Acetyl Co-A Metabolizing Enzymes as Potential Drug Targets against Mycobacterium tuberculosis — shares topic coverage
- Indole-Based Macrocyclization by Metal-Catalyzed Approaches — shares topic coverage
- Hyphenated Techniques in Liquid Chromatography as Current Trends in Natural Products Analysis — shares topic coverage
- Sensitivity of NMR-based Metabolomics in Drug Discovery from Medicinal Plants — shares topic coverage
- Pharmacovigilance in Cameroon: Past, Present and Future Developments in Unlocking the Drug Development Process — shares topic coverage
Article metrics
Real usage data collected on this platform.
3
Page views
0
PDF downloads
0
Outbound clicks
15
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.